Literature DB >> 12125141

Human antibody subclass ELISA.

Pierre Druilhe1, Hasnaa Bouharoun-Tayoun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125141     DOI: 10.1385/1-59259-271-6:457

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  4 in total

1.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.

Authors:  Gilles Bang; Eric Prieur; Christian Roussilhon; Pierre Druilhe
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

3.  Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.

Authors:  John P A Lusingu; Samwel Gesase; Salum Msham; Filbert Francis; Martha Lemnge; Misago Seth; Samwel Sembuche; Acleus Rutta; Daniel Minja; Method D Segeja; Samuel Bosomprah; Simon Cousens; Ramadhani Noor; Roma Chilengi; Pierre Druilhe
Journal:  Malar J       Date:  2009-07-17       Impact factor: 2.979

4.  A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum.

Authors:  Subhash Singh; Soe Soe; Simon Weisman; John W Barnwell; Jean Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.